Purpose-Surgical-trauma-induced edema and its protracted resolution can lead to significant dose reduction in pre-planned 131 Cs prostate brachytherapy. The purpose of this work was to examine whether these dose reductions should be actively compensated and to estimate the magnitude of additional irradiations needed for dose compensation.Methods and Materials-Quantitative edema resolution characteristics observed by Waterman et. el. were used to examine the physical and radiobiological effects of prostate edema in preplanned 131 Cs implants. The need for dose compensation was assessed based on the dose-responses observed in 125 I and 103 Pd prostate implants. Biologically effective dose calculated with full consideration of edema evolution was used to estimate the additional irradiations needed for dose compensation.Results-Edema-induced dose reduction in pre-planned 131 Cs implants could easily exceed 10% prescription dose for implants with moderate or large edemas. These dose reductions could lead to more than 10% reduction in biochemical recurrence-free survival for individual patients if the effect of edema was ignored. For a prescribed dose of 120 Gy, the number of 2-Gy external-beam fractions needed to compensate a 5%, 10%, 15%, 20%, or 25% edema-induced dose reduction could be 1, 4, 6, 7, or 9, respectively, for prostate cancers with a median potential doubling time of 42 days. The required additional irradiation increases for tumors that are fast growing and/or are less efficient in sub-lethal damage repair.Conclusions-Compensation of edema-induced dose reductions in pre-planned 131 Cs prostate brachytherapy should be actively considered for those implants with moderate or large edemas.